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High Myopia Caused by a Mutation
in LEPREL1, Encoding Prolyl 3-Hydroxylase 2
Shikma Mordechai,1,6 Libe Gradstein,2,6 Annika Pasanen,3,4 Rivka Ofir,1 Khalil El Amour,5 Jaime Levy,2
Nadav Belfair,2 Tova Lifshitz,2 Sara Joshua,1 Ginat Narkis,1,5 Khalil Elbedour,5 Johanna Myllyharju,3,4
and Ohad S. Birk1,5,*
Autosomal-recessive high-grade axial myopia was diagnosed in Bedouin Israeli consanguineous kindred. Some affected individuals also
had variable expressivity of early-onset cataracts, peripheral vitreo-retinal degeneration, and secondary sight loss due to severe retinal
detachments. Through genome-wide linkage analysis, the disease-associated gene was mapped to ~1.7 Mb on chromosome 3q28 (the
maximum LOD score was 11.5 at q ¼ 0 for marker D3S1314). Sequencing of the entire coding regions and intron-exon boundaries of
the six genes within the defined locus identified a single mutation (c.1523G>T) in exon 10 of LEPREL1, encoding prolyl 3-hydroxylase
2 (P3H2), a 2-oxoglutarate-dependent dioxygenase that hydroxylates collagens. The mutation affects a glycine that is conserved within
P3H isozymes. Analysis of wild-type and p.Gly508Val (c.1523G>T) mutant recombinant P3H2 polypeptides expressed in insect cells
showed that the mutation led to complete inactivation of P3H2.Myopia is the most common human eye disorder and
constitutes a significant public health concern.1 Specifi-
cally, high myopia is a leading cause of visual impairment
and blindness worldwide because of its associated ocular
comorbidities of retinal detachment, macular degenera-
tion, premature cataract, and glaucoma.1,2 Childhood
myopia is primarily due to growth in axial length of the
eyeball; most cases are either congenital (usually high
myopia) or juvenile (onset between 7 and 16 years of
age). In general, the earlier the onset of myopia occurs,
the greater the degree of progression.1,2 Twin studies and
heritability measures suggest a strong genetic component
in myopia.3,4 Myopia is mostly regarded as a multifactorial
polygenic disorder.1 Genome-wide association studies of
the common presumably polygenic multifactorial myopia
in large cohorts have recently identified association
with genomic loci at chromosomes 13q12,5 15q14,6 and
15q25,7 as well as with genetic variants in CTNND2
(MIM 604275) at 5p15.8 There are more than 150 defined
monogenic syndromes in which familial high myopia is
one of the features.1,3 These syndromes are associated
with a range of other phenotypic changes, and most are
associated with severe congenital myopia.3 Some
syndromes affect processes, such as retinal processing,
that are likely to be important in the regulation of eye
size or affect the properties of connective-tissue macromol-
ecules such as collagen.3 Pedigrees of apparently mono-
genic nonsyndromic hereditary myopia were previously
described and were mostly found to be autosomal domi-
nant; rarely, they were found to be X linked or reces-
sive.1,9 At least 17 susceptibility loci have been described1The Morris Kahn Laboratory of Human Genetics, National Institute for Biot
84105, Israel; 2Department of Ophthalmology, Soroka Medical Center and C
the Negev, Beer-Sheva 84101, Israel; 3Biocenter Oulu, University of Oulu, FIN-9
ment of Medical Biochemistry and Molecular Biology, University of Oulu, FIN
Beer-Sheva 84101, Israel
6These authors contributed equally to this work
*Correspondence: obirk@bgu.ac.il
DOI 10.1016/j.ajhg.2011.08.003. 2011 by The American Society of Human
438 The American Journal of Human Genetics 89, 438–445, Septembfor nonsyndromic monogenic myopia.1,9 However, no
clear causative gene mutations have been identified so far
in these loci.
Large consanguineous Israeli Bedouin kindred presented
with an apparently autosomal-recessive phenotype of non-
syndromic severe myopia with variable expressivity of
cataract and vitreo-retinal degeneration (Figure 1). Thir-
teen affected and 32 unaffected individuals (M1–M45,
Figure 1) of the kindred underwent complete ophthalmic
examination, including slit-lamp biomicroscopy, indirect
ophthalmoscopy, measurement of visual acuity and refrac-
tive errors, and examination of eye movements and ocular
alignment. The study was approved by the Soroka Medical
Center institutional review board and the Israeli Helsinki
Committee for genetic studies, and informed consent
was obtained from all individuals studied.
The affected individuals (seven males and six females,
ages 7 to 65 years) were examined by a clinical geneticist
and had no apparent dysmorphology. They all appeared
normal at birth and presented with poor sight in child-
hood. In addition to myopia, many affected individuals
developed cataracts and peripheral vitreo-retinal degenera-
tion, and some had subluxated lenses. The onset of myopia
usually preceded that of the cataracts and the retinal
degeneration. Most affected individuals had high myopia
between 5 and 18 diopters (Table 1), but two had
mild myopia. Preoperative refractive error was not avail-
able in two patients and in one eye of other three patients.
Table 1 shows the spherical equivalent of myopia, calcu-
lated for each eye as a sphere plus half of the cylinder of the
refractive error. Mean refractive error was 11.3 diopters.echnology in the Negev, Ben Gurion University of the Negev, Beer-Sheva
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Figure 1. Pedigree of Affected Israeli-Bedouin Kindred
Solid and open symbols represent affected and unaffected individuals, respectively. M numbers denote individuals whose DNA samples
were analyzed. Because of the complexity of the pedigree, some individuals (M3, M5, M7, M19, M20, M21, M23, and M31) are drawn
twice, with the same M number.All patients had axial myopia, as evidenced by an increased
axial length of the eye (the length ranged between 25.1
and 30.5 mm; Table 1). Eleven patients developed cataracts
that were significant enough to warrant surgery in one or
both eyes, usually in the first or second decade of life. In
three patients, subluxated lenses were detected and were
associated with cataracts in two patients and lens colo-
boma in one of them. In an additional five patients, lens
instability due to weak or partially missing lens zonules
was found during cataract surgery. This caused surgical
complications, including rupture of the lens capsule and
decentration of the inserted intraocular lens, which
required reoperation. In four patients, lens instability
made it impossible to insert the intraocular lens at all,
which left them aphakic. Peripheral vitreo-retinal degener-
ative changes were found in nine patients (Table 1), four of
whom developed retinal tears (mostly dialyses) causing
retinal detachment in one or both eyes. In three patients
(23% of affected individuals), in spite of multiple surgical
procedures, intractable retinal detachments led to blind-
ness in one eye.
Assuming a founder effect, we studied 11 affected indi-
viduals and seven healthy individuals by performing a
genome-wide linkage analysis with 400 fluorescently
end-labeled polymorphic markers (ABI PRISM Linkage
Mapping Set MD10 [Applied Biosystems]) as previously
described.10 PCR products were separated by electropho-
resis on an ABI PRISM 377 DNA Sequencer (Applied
Biosystems) and analyzed with Gene-Scan software
(detailed results in Document S1). Fine-mapping was
carried out using polymorphic markers as previously
described.10 Haplotypes were manually constructed and
analyzed. Noninformative regions were excluded by the
use of additional adjacent microsatellite markers. Analysis
of the results with SUPERLINK software11 yielded two loci
with LOD scores above two: a LOD score of 4.1764 at
marker D3S3530 and a LOD score of 3.04 at marker
D7S484. Fine mapping at the chromosome 7 locus ruled
out its association with the disease (Document S2). We per-
formed fine mapping surrounding D3S3530 by using the
following additional polymorphic markers to test DNA
samples of the 45 available family members (13 affectedThe Americanand 32 unaffected): D3S1580, D3S3549, D3S2398, D3S_A,
D3S1294, D3S1314, D3S1288, D3S2747, D3S3043, D3S_B,
D3S2455, and D3S1601 (D3S_A and D3S_B are polymor-
phic markers designed with Tandem Repeats Finder;
primer sequences are given in Document S3). As seen in
Figure 2, an interval of homozygosity common to all
affected individuals in the family was demonstrated
between markers D3S3530 and D3S2455. Six affected
individuals (M2, M14, M15, M17, M18, and M25) lacked
homozygosity at D3S3530, setting the upper limit of the
homozygosity interval at D3S3530 (Figure 2). Ten affected
individuals (M2, M8, M14, M11, M12, M15, M17, M18,
M29, and M25) presented with a recombination event at
D3S2455, setting the lower limit of the homozygosity
interval at D3S2455. The common haplotype indicated a
minimal candidate interval of 1.7 Mbp (~4 cM) that con-
tained six known or predicted genes. Linkage was demon-
strated by two-point analysis with SUPERLINK,11 which
provided a LOD score of 11.5 at q ¼ 0 for Marker
D3S1314 (data available upon request).
On the basis of data from the UCSC Genome Browser,
only six genes were located within the identified interval.
Their coding sequences and exon-intron boundaries were
amplified from genomic DNA with PCR primers designed
with the Primer3 program; all primer sequences are given
in Document S3). PCR products were subject to agarose-
gel electrophoresis and gel extraction (QIAGEN), followed
by sequencing with either the forward or reverse primer on
an ABI PRISM 377 DNA Sequencer (Applied Biosystems).
Results were analyzed with ChromasPro software, and
the obtained DNA sequences were compared with pub-
lished sequences (BLAST software). No mutations were
found in the coding regions or intron-exon boundaries
of five genes within the 3q28 locus. As shown in Figures
3A–3C, sequence analysis of LEPREL1 (RefSeq number
NM_018192.3; MIM 610341) revealed that exon 10 con-
tained a c.1523G>T mutation, which led to the replace-
ment of glycine at position 508 by valine (p.Gly508Val;
c.1523G>T) in the encoded protein, LEPREL1 (Leprecan-
Like 1, termed also P3H2). It should be noted that LEPREL1
was suggested by our S2G software12 to be the top candi-
date gene of the six genes within the locus.Journal of Human Genetics 89, 438–445, September 9, 2011 439
Table 1. Clinical Data of Affected Individuals
Number Sex
Age
(y)
Myopia (diopters)a Axial length (mm) Cataract Cataract surgery age (y)
Vitreo-Retinal
Changes CommentsOD OS OD OS OD OS OD OS
M14 M 17 8.00 5.00 27.7 26. 3 yes yes 9 13 OU vitreous opacities
OD retinal dialysis
and detachment
OS retinal tears
OU rupture of lens
capsule in cataract
surgery, aphakia
OD glaucoma,
and blindness
M15 F 23 1.00 NA 25.1 25.5 yes yes 23 20 OD pigmented
retinal scar
M35 M 13 14.50 14.50 28.9 28.8 yes yes 9 8 OD vitreous
opacities, OS
lattice degeneration
OU zonulolysis
and phacodonesis
seen in cataract
surgery, aphakia
M11 M 12 8.00 11.00 NA NA no no no no no OU subluxated lenses
M12 F 17 11.50 13.50 NA NA no yes no 17 no
M17 M 28 1.25 NA NA NA yes yes no 13 OD retinal tears
and detachment
OS retinal dialysis
and total detachment
OS blind
M18 F 25 NA NA NA NA yes yes 20 15 OU fine vitreous
opacities
OU rupture of lens
capsule in cataract
surgery, OS
subluxated IOL
M29 F 7 12.00 10.50 NA NA no no no no no
M2 F 65 NA NA NA NA yes yes 41 46 OD lattice
degeneration,
OS retinal dialysis
& detachment
OD aphakia OS
subluxated IOL
M25 F 24 NA 11.00 26.0 27.3 yes yes 7 no OD retinal dialysis
and detachment,
OS vitreous opacities
OD blind OS
subluxated lens,
lens coloboma
M28 M 13 16.00 18.00 28.4 27.6 yes yes 7 7 no OU subluxated lenses,
aphakia, OS rupture
of lens capsule in
cataract surgery
M36 M 16 15.00 17.00 30.5 29.5 yes yes no 12 OU lattice
degeneration
and vitreous veils
OS reoperation for
subluxated IOL due to
rupture of lens capsule
M8 M 29 13.00 14.00 >26.5 >26.5 yes yes 8 7 OU vitreous opacities deafness
Abbreviations are as follows: OD, right eye; OS, left eye; OU, both eyes; F, female; M, male; NA, data not available; and IOL, intraocular lens.
a Spherical equivalent of myopia is shown, calculated for each eye as a sphere plus half of the cylinder of the refractive error.To test for the mutation in a larger cohort, we amplified
genomic DNA from 45 individuals of the pedigree and
from 200 unrelated controls by using the following PCR
primers: 50-TGGAATAAAATGGGGATGGT-30 and 50-TCTG
CCATTTACAGAAGCCTTA-30. We analyzed PCR products
by denaturing high-performance liquid chromatography
(DHPLC, WAVE Nucleic Acid Fragment Analysis System,
Transgenomics). Analysis of all 45 DNA samples of the
kindred was compatible with association of the mutation
with the disease phenotype, implying full penetrance
with variable expressivity. The mutation was not found
in any of 400 chromosomes from ethnically matched
controls tested by DHPLC. It should be noted that the
glycine at position 508 of LEPREL1 is conserved
throughout evolution (Figure 3D). As seen in Figure 3E,
the p.Gly508Val mutation is predicted to alter the three-440 The American Journal of Human Genetics 89, 438–445, Septembdimensional structure of the prolyl-hydroxylase encoded
by LEPREL1 (NNpredict).13
To test for functional consequences of the LEPREL1
mutation, we analyzed wild-type and p.Gly508Val mutant
recombinant human P3H2 polypeptides expressed in
insect cells. The P3H2 p.Gly508Val mutation was intro-
duced into the pVL1392-P3H2 plasmid14 with the Quick-
ChangeXL site-directed mutagenesis kit (Stratagene). The
recombinant vector was cotransfected into Spodoptera
frugiperda (Sf9) insect cells with modified Autographa
californica nuclear polyhedrosis virus DNA (BaculoGold,
PharMingen) by calcium phosphate transfection, and the
recombinant viruses were amplified.15 Monolayer cultures
of Sf9 cells in TNM-FH medium (Sigma) supplemented
with 10% fetal bovine serum (HyClone) were infected
with the recombinant viruses coding for wild-type orer 9, 2011
Figure 2. Defining the Disease-Associated Locus
A partial pedigree of the large Israeli-Bedouin kindred is shown. The disease-associated haplotype is boxed. The minimal homozygosity
locus associated with the disease is defined between themarkers D3S3530 and D3S2455. Individuals are given the sameM numbers as in
Figure 1 and Table 1.
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Figure 3. Analysis of the c.1523G>T
(p.Gly508Val) Mutation in Exon 10 of LEPREL1
Sequence analysis is shown for an affected indi-
vidual (A), an obligatory carrier (B), and an unaf-
fected individual (C). The glycine at position 508
of LEPREL1 is conserved throughout evolution
(D). (E) Changes in secondary structure as a result
of the valine-to-glycine substitution.mutant P3H2 at a multiplicity of 5 and a cell density of 53
106 per 100 mm plate. The cells were harvested 72 hr after
infection, washed with a solution of 0.15 M NaCl and
0.02 M phosphate (pH 7.4; PBS), and homogenized in
a solution of 0.1 M NaCl, 0.1 M glycine, 2 mM CaCl2,
10 mM dithiothreitol, 0.1% Triton X-100, 0.01 M Tris
(pH 7.8), and the complete EDTA-free protease inhibitor
cocktail (Roche Diagnostics), and centrifuged at 13,000 x g
for 20 min. The remaining pellets were solubilized in 1%
SDS, and aliquots of both fractions were analyzed by
15% SDS-PAGE under reducing conditions followed by
Coomassie Blue staining or ECL-immunoblotting (Amer-
sham Biosciences) with a polyclonal antibody against
P3H214 at a 1:500 dilution. Equal amounts of soluble
wild-type and mutant P3H2 polypeptides were found
in the Triton X-100-soluble fractions (not shown) that
were assayed for P3H activity by a method based on the
hydroxylation-coupled decarboxylation of 2-oxo-[1-14C]
glutarate16 with differing amounts of a peptide substrate
(Gly-Pro-4Hyp)5, (Innovagen). In additional experiments,
the peptide substrate was replaced by the synthetic
peptides Ser-Lys-Gly-Glu-Gln-Gly-Phe-Met-Gly-Pro-4Hyp-
Gly-Pro-Gln-Gly-Gln-4Hyp-Gly-Leu-4Hyp-Gly or Pro-Thr-
Gly-Pro-Arg-Gly-Phe-Pro-Gly-Pro-4Hyp-Gly-Pro-Asp-Gly-Ley-
4Hyp-Gly-Ser-Met-Gly, corresponding to two known
prolyl 3-hydroxylation sites in the collagen IV a1 chain17
or by Leu-Asn-Gly-Leu-4Hyp-Gly-Pro-Ile-Gly-Pro-4Hyp-
Gly-Pro-Arg-Gly-Arg-Thr-Gly-Asp-Ala-Gly, corresponding
to the only prolyl 3-hydroxylation site in the collagen I
a1 chain at position 986 of the triple helix.18 Triton
X-100 extracts of insect cells expressing human collagen
prolyl 4-hydroxylase isoenzyme II (C-P4H-II)19 were used442 The American Journal of Human Genetics 89, 438–445, September 9, 2011as negative controls. A large amount of
P3H activity was obtained in the P3H2
sample when the synthetic peptide (Gly-
Pro-4Hyp)5 was used as the substrate,
whereas the activity of the p.Gly508Val
mutant P3H2 never exceeded the back-
ground values (Table 2). Also, the mutant
P3H2 polypeptide did not show any
activity when synthetic peptides represent-
ing the known prolyl 3-hydroxylation sites
in human type I and type IV collagen poly-
peptides were used as substrates (data not
shown).
LEPREL1 is localized to the ER and the
Golgi network.20 The 708 amino acid pro-
tein contains a signal sequence, four tetra-tricopeptide repeats (TPRs), a leucine zipper, a P loop,
and a C-terminal region that contains the catalytically
critical residues that are required for binding of Fe2þ and
2-oxoglutarate and are shared with the collagen-modifying
lysyl hydroxylases and prolyl 4-hydroxylases, as well
as other 2-oxoglutarate-dependent dioxygenases and a
C-terminal KDEL ER-retention motif.19,20 The mutation
results in a glycine-to-valine substitution at amino acid
508 within the C-terminal region.19 The mutated glycine
is a highly conserved residue within the P3H family
(Figure 3D), suggesting its importance: the p.Gly508Val
variant is predicted (via PolyPhen algorithms) to be
probably damaging with a position-specific independent
counts (PSIC) score difference of 2.423; moreover, sub-
stitution of glycine with valine leads to putative changes
in the secondary structure of the protein (Figure 3E).13
Accordingly, the p.Gly508Val mutation led to complete
inactivation of recombinant P3H2 polypeptide expressed
in insect cells, both when analyzed with a (Gly-Pro-
4Hyp)5 peptide substrate that fulfills the substrate require-
ments of P3H and when analyzed with synthetic peptides
representing known prolyl 3-hydroxylation sites in human
type I and type IV collagen polypeptides.
The large kindred presented here is distinctive in its
recessive heredity of myopia. Interestingly, a study of
juvenile cataract with myopia in a Chinese family demon-
strated linkage to a locus between D3S3606 and D3S1262,
approximately 3 Mbp from the region highlighted in our
kindred;21 however, the genomic loci in the two kindreds
do not overlap. In contrast with that of the Bedouin
kindred, the phenotype in the Chinese family was domi-
nantly inherited, manifested as cataracts with likely
Table 2. P3H Activities of Triton X-100-Soluble Fractions of Insect
Cells Expressing Wild-Type P3H2, p.Gly508Val Mutant P3H2, or
C-P4H-II with the peptide (Pro-4Hyp-Gly)5 as the Substrate
Enzyme
Peptide
Concentration (mM)
Activity
(dpm/100 mla)
P3H2 50 4570 5 320
100 8170 5 610
P3H2Gly508Val 50 <100
100 <100
C-P4H-IIb 100 <100
100 <100
a The values are means 5 SD from at least three independent experiments.
b The Triton X-100-soluble fraction of insect cells expressing C-P4H-II was used
as a negative control.secondary myopia that appeared in only some of the
affected individuals, and was found to be associated with
a heterozygous mutation in BFSP2 (MIM 603212), a gene
known to be mutated in dominant cataracts.21
The homozygous LEPREL1 mutation identified in
affected individuals of the Bedouin kindred was associ-
ated with full penetrance and variable expressivity of
the disease. The main clinical phenotype was severe
myopia. However, cataracts, vitreo-retinal degeneration,
and subluxated lenses were also found in some patients.
These led to severe ocular morbidity and a high rate of
surgical complications, which resulted in blindness in
23% of our patients. We clearly demonstrate that the
myopia is due to increased axial eye length, although
one cannot rule out the possibility that changes in the
lens might also contribute to the myopia phenotype.
Although the cataract and vitreo-retinal degeneration
might be related to the myopia, it is plausible that the
myopia, cataracts, vitreo-retinal degeneration, and lens
subluxation are all independent consequences of the
LEPREL1 mutation.
The association of the LEPREL1 mutation with ocular
abnormalities is in line with previous findings: LEPREL1
is found in a wide variety of tissues, including the eye;22
specifically, it was demonstrated in the iris, lens, trabecular
meshwork, and retinal pericyte cells (NEIBank). Recent
protein-localization studies of the P3H isoenzymes in
mouse demonstrated that P3H2 appears to be coordinately
expressed with and therefore recognizes basement
membrane collagens such as type IV collagen.23 Further-
more, it was suggested that other basement-membrane-
associated collagens may be targets of this enzyme as
well.23 It is noteworthy that collagen type IV is found in
various ocular structures, including the lens, iris, retina,
retinal pigment epithelium, and trabecular meshwork
(NEIBank). Interestingly, P3H2 is expressed in the devel-
oping lens capsule of mouse embryos (E11–E15).23 Because
the lens capsule is a basement membrane whose main
component is type IV collagen, these findings further
suggest that defective collagen hydroxylation as a resultThe Americanof P3H2 inactivation might cause abnormality of the
lens capsule, possibly leading to the development of cata-
racts and possibly contributing to the myopia phenotype
by affecting distensibility of the lens capsule. An abnor-
mally weak lens capsule can also account for a capsular
rupture during cataract surgery; such a rupture occurred
in many of our patients. Because type IV collagen has
been demonstrated in the ciliary zonules of the eye
(suspensory ligament of the lens),24 its abnormality may
cause a defective zonular structure. Weakening of the zon-
ules probably underlies lens instability, as evidenced by
spontaneous lens subluxation in some of our patients, as
well as pathological zonulolysis during cataract surgery
in others.
Another basement membrane in the eye is the inner
limiting membrane (ILM) of the retina. It has been shown
that ILM is important for proper retinal development
and in the early regulation of eye size: ILM disruption
resulted in marked eye enlargement in chick embryos,
implicating that defective ILM might lead to congenital
high myopia.25 Inactivation of P3H2 as a result of the
LEPREL1mutation in our patients might cause a weakened
retinal ILM and thus lead to excessive eye growth and
development of myopia. Likewise, a defective retinal base-
ment membrane harbors greater risk for retinal tears and
dialyses, which can lead to retinal detachments such as
those observed in some of our patients. This predisposi-
tion, in addition to complicated cataract surgery, might
have further aggravated the prognosis of retinal detach-
ments in our patients.
It is worth noting that defects in collagen hydroxylation
have been previously demonstrated to cause phenotypes
similar to those caused by collagen mutations: autosomal-
recessive variants of osteogenesis imperfecta, a disease
known to be caused by dominant collagen mutations,
can be caused by defects in collagen prolyl 3- hydroxyl-
ation.18,26,27 Development of myopia has been shown to
be associated with decreased rates of collagen synthesis
in the sclera.28 Moreover, various clinical syndromes
such as Stickler syndrome (MIM 108300), Marshall syn-
drome (MIM 154780), and Weissenbacher-Zweymuller
syndrome (MIM 277610), in which myopia is a prominent
feature, are caused by defects in collagens.3,4 Thus, whereas
mutations in collagen genes cause autosomal-dominant
myopia syndromes, defects in collagen hydroxylation
might cause autosomal-recessive myopia. It of course yet
remains to be tested whether P3H2 modifies the collagens
known to act in those processes. Our findings demonstrate
a significant role of LEPREL1 in the molecular pathways of
ocular growth, as well as in the development of myopia
and cataracts. Further studies will need to explore whether
LEPREL1mutations or polymorphisms are associated with
ocular abnormalities in a wider population. An improved
understanding of the molecular basis of pathological
myopia might allow early diagnosis and treatment and
thus prevent irreversible visual loss, as developed in our
patients.Journal of Human Genetics 89, 438–445, September 9, 2011 443
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